Swiss Nordic Bio 2026

1 Oct 2026 | Zürich, Switzerland

Register
Register
Register

Boehringer Ingelheim International GmbH

Big Pharma

Biberach an der Riss, Germany

About

Business Development & Licensing

Areas of Activity

Biotech / Pharma

Phase of our company

Discovery & developmentPreclinical researchClinical research

Therapeutic areas

Cardiology/Vascular DiseasesGastroenterologyImmunologyOncologyPulmonary/Respiratory DiseasesRheumatology

We are looking for

Research partner

Representatives

Director, Strategic Partnering TA Inflammation & NCE Technologies, Global BD&L

Boehringer Ingelheim International GmbH